Compare IDXX & RELX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | RELX |
|---|---|---|
| Founded | 1983 | 1903 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0B | 73.3B |
| IPO Year | 1991 | N/A |
| Metric | IDXX | RELX |
|---|---|---|
| Price | $720.82 | $42.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $700.50 | N/A |
| AVG Volume (30 Days) | 516.2K | ★ 1.9M |
| Earning Date | 02-02-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 2.03% |
| EPS Growth | ★ 21.65 | 3.29 |
| EPS | ★ 12.60 | 1.42 |
| Revenue | $4,167,411,000.00 | ★ $13,062,063,298.00 |
| Revenue This Year | $12.15 | $6.02 |
| Revenue Next Year | $8.72 | $6.61 |
| P/E Ratio | $57.52 | ★ $30.20 |
| Revenue Growth | ★ 8.39 | 2.48 |
| 52 Week Low | $356.14 | $39.31 |
| 52 Week High | $769.98 | $56.33 |
| Indicator | IDXX | RELX |
|---|---|---|
| Relative Strength Index (RSI) | 60.56 | 59.23 |
| Support Level | $702.01 | $41.84 |
| Resistance Level | $725.53 | $43.36 |
| Average True Range (ATR) | 15.04 | 0.60 |
| MACD | 4.15 | 0.26 |
| Stochastic Oscillator | 94.73 | 77.93 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
RELX is a global provider of information-based analytics and decision tools for professional and business customers in various industries. The company serves sectors such as science and medical research, risk management, and legal. In addition, RELX organizes large-scale digital and face-to-face events such as industry trade shows. Around 60% of revenue is generated in North America and about 20% in Europe.